Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−41.81 MXN
17.08 B MXN
70.13 B MXN
237.11 M
About BioNTech SE
Sector
Industry
CEO
Ugur Sahin
Website
Headquarters
Mainz
Founded
2008
FIGI
BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where BNTX/N is featured.
Frequently Asked Questions
The current price of BNTX/N is 2,240.00 MXN — it has decreased by −2.61% in the past 24 hours. Watch BIONTECH SE stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BIVA exchange BIONTECH SE stocks are traded under the ticker BNTX/N.
BNTX/N stock has fallen by −3.60% compared to the previous week, the month change is a −3.00% fall, over the last year BIONTECH SE has showed a 33.68% increase.
We've gathered analysts' opinions on BIONTECH SE future price: according to them, BNTX/N price has a max estimate of 3,450.75 MXN and a min estimate of 1,802.87 MXN. Watch BNTX/N chart and read a more detailed BIONTECH SE stock forecast: see what analysts think of BIONTECH SE and suggest that you do with its stocks.
BNTX/N stock is 2.69% volatile and has beta coefficient of 0.88. Track BIONTECH SE stock price on the chart and check out the list of the most volatile stocks — is BIONTECH SE there?
Today BIONTECH SE has the market capitalization of 521.33 B, it has increased by 3.85% over the last week.
Yes, you can track BIONTECH SE financials in yearly and quarterly reports right on TradingView.
BIONTECH SE is going to release the next earnings report on Mar 10, 2025. Keep track of upcoming events with our Earnings Calendar.
BNTX/N earnings for the last quarter are 17.77 MXN per share, whereas the estimation was −33.65 MXN resulting in a 152.80% surprise. The estimated earnings for the next quarter are 18.51 MXN per share. See more details about BIONTECH SE earnings.
BIONTECH SE revenue for the last quarter amounts to 27.31 B MXN, despite the estimated figure of 11.28 B MXN. In the next quarter, revenue is expected to reach 25.73 B MXN.
BNTX/N net income for the last quarter is −15.95 B MXN, while the quarter before that showed −5.67 B MXN of net income which accounts for −181.43% change. Track more BIONTECH SE financial stats to get the full picture.
BIONTECH SE dividend yield was 0.00% in 2023, and payout ratio reached 0.00%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 6, 2024, the company has 3.08 K employees. See our rating of the largest employees — is BIONTECH SE on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIONTECH SE EBITDA is −6.59 B MXN, and current EBITDA margin is 28.52%. See more stats in BIONTECH SE financial statements.
Like other stocks, BNTX/N shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIONTECH SE stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIONTECH SE technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIONTECH SE stock shows the neutral signal. See more of BIONTECH SE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.